Laron syndrome (LS), or primary growth hormone (GH) insensitivity, was first described in 1966. Together, this book condenses, consolidates, compares, and contrasts data derived from the human and mouse LS experiences and provides a unique resource for clinical and basic scientists to evaluate and compare IGF-I and GH actions.